Stay updated on Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.

Latest updates to the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision number was introduced (v3.6.3), replacing the previous v3.6.2; this indicates a small platform/template update with no changes to the study information shown on the page.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page shows a new revision label, updating from v3.6.0 to v3.6.2. This indicates a software/build version change rather than a change to study data or page content.SummaryDifference0.0%

- Check33 days agoChange DetectedRecruitment has been closed on this study page, indicating that enrollment is no longer being sought. New help sections have been added to guide readers on how to interpret the study record and how to join a study, and the page’s revision tag has been updated to v3.6.0 with a minor heading formatting adjustment to Intervention/Treatment.SummaryDifference0.4%

- Check40 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a minor update to the page's system or template rather than the study data.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page now shows Revision: v3.5.4, indicating a newer build of the study entry.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page's revision history now shows Revision: v3.5.3, replacing the previous Revision: v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.